Takeover of Prosensa Holding NV (NASDAQ:RNA) Under Investor Investigation
An investigation on behalf of investors, who currently hold shares of Prosensa Holding NV (NASDAQ:RNA), was announced concerning whether the takeover of Prosensa Holding NV. by BioMarin Pharmaceutical Inc for $17.75 per share is unfair to NASDAQ:RNA stockholders.
View full press release